Atomwise patented the first deep learning technology for structure-based small molecule drug discovery. This AI technology harnesses millions of data points and thousands of protein structures to solve problems that a human chemist would take many lifetimes to solve.
Abraham Heifets
Dr. Izhar Wallach
Abraham Heifets
February 2018